Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression
Cancer researchers describe a novel therapeutic strategy to overcome tumor-induced immunosuppression. For the first time, the research team identified a critical immunosuppressive pathway and a promising approach to intervene, protecting the ability of T-cells to attack cancer cells.
Materials provided by Louisiana State University Health Sciences Center. Note: Content may be edited for style and length.
Source link aaaaa